Reduction of C/EBPα gene expression occurred in hepatocellular carcinoma, skin carcinoma and lung cancer, in particular in lung adenocarcinomas, which had the most significant and frequent reduction in C/EBPα gene expression[4]. Here, CEBPA is linked to hepatocellular carcinoma.